Stanford's Virtual Biotech of 37,000 AI Agents Designs Validated Lung Cancer Therapy

Stanford Medicine's James Zou team built a virtual biotech company staffed by 37,000 AI agents with a 'chief scientist' coordinating round-the-clock drug discovery. Reported in Nature, the system predicted trial outcomes and independently designed a lung cancer therapy that was validated in experiments.

2026-11-10 ~ 2026-11-10 · 3 related posts

• 37,000 AI agents predicted drug trial success and designed a lung cancer therapy later validated — burny_tech · 2026-11-10
• Stanford spins out virtual biotech run by 37,000 AI agents that designed a lung cancer therapy later validated in trials — burny_tech · 2026-11-10
• 37,000 AI agents in a 'virtual biotech' discover promising lung-cancer drug — burny_tech · 2026-11-10